Insulin resistance, chronic stress, poor sleep, and certain medications (antidepressants, antipsychotics, corticosteroids) can counteract appetite suppression
Additional dosing resources include the compounded semaglutide dose chart , the compounded semaglutide with B12 dosage chart , the compounded tirzepatide starting dose guide , and the tirzepatide compound dosage chart
Semaglutide works through several key mechanisms: 1
EECs are classically characterized based on the gut hormones they secrete, such as L-cells (GLP-1), I-cells (CCK), and K-cells (GIP) 83
[1] [3] Key risk factors for developing hypotension on GLP-1 therapy include: Concurrent use of antihypertensive medications, especially diuretics, ACE inhibitors, or ARBs Concomitant use of SGLT2 inhibitors, which can cause osmotic diuresis and volume depletion Baseline blood pressure in the low-normal range (systolic 90-110 mmHg) Advanced age (65 years and older) Autonomic dysfunction or diabetic neuropathy Rapid or substantial weight loss Inadequate fluid intake or gastrointestinal side effects causing dehydration Concomitant use of other medications that lower blood pressure Patients with type 1 diabetes using off-label GLP-1 therapy or those with longstanding type 2 diabetes and cardiovascular autonomic neuropathy may be at higher risk for orthostatic hypotension
These medications arent exactly the same as the GLP-1 your body makes and thats a good thing